Marco Mura

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 15

Top Venues

Respirology (Carlton, Vic.)

Lung

Respiratory research

Therapeutic advances in respiratory disease

Western University

Universita degli Studi di Bologna Azienda Ospedaliera Sant'Orsola-Malpighi (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Western University Aug 01 2012

Canada

Associate Professor of Medicine :: Medicine

Education History

Universita degli Studi di Bologna Azienda Ospedaliera Sant'Orsola-Malpighi Jan 01 2002 - Apr 18 2005

Italy

PHD :: Medicine

Publications

Umberto Zanini, Fabrizio Luppi, Karina Kaur, Niccolò Anzani, Giovanni Franco, Giovanni Ferrara, Meena Kalluri, Marco Mura
Use of 6-minute walk distance to predict lung transplant-free survival in fibrosing non-IPF interstitial lung diseases. Respirology (Carlton, Vic.) (2024)
Umberto Zanini, Fabrizio Luppi, Karina Kaur, Niccolò Anzani, Giovanni Franco, Giovanni Ferrara, Meena Kalluri, Marco Mura
Use of 6-minute walk distance to predict lung transplant-free survival in fibrosing non-IPF interstitial lung diseases. Respirology (Carlton, Vic.) 29 (5) (2024)
Umberto Zanini, Fabrizio Luppi, Karina Kaur, Niccolò Anzani, Giovanni Franco, Giovanni Ferrara, Meena Kalluri, Marco Mura
Use of 6-minute walk distance to predict lung transplant-free survival in fibrosing non-IPF interstitial lung diseases. Respirology (Carlton, Vic.) 29 (5) (2024)
Jonathan Keow, Matthew J Cecchini, Nathashi Jayawardena, Maurizio Zompatori, Mariamma G Joseph, Marco Mura
Digital quantification of p16-positive foci in fibrotic interstitial lung disease is associated with a phenotype of idiopathic pulmonary fibrosis with reduced survival. Respiratory research 23 (1) (2022)
Luke M Kraven, Adam R Taylor, Philip L Molyneaux, Toby M Maher, John E McDonough, Marco Mura, Ivana V Yang, David A Schwartz, Yong Huang, Imre Noth, Shwu Fan Ma, Astrid J Yeo, William A Fahy, R Gisli Jenkins, Louise V Wain
Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis. Thorax (2022)
Laura van den Bosch, Fabrizio Luppi, Giovanni Ferrara, Marco Mura
Immunomodulatory treatment of interstitial lung disease. Therapeutic advances in respiratory disease 16 (2022)
Sylvia Rinaldi, Jason A Gilliland, Colleen O'Connor, Jamie A Seabrook, Marco Mura, Janet Madill
Exercise capacity and its relationship with body composition and nutrition status in patients with interstitial lung disease. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 36 (4) (2021)
Vincenzo Zagà, Marco Dell'Omo, Nicola Murgia, Marco Mura
Tobacco Worker's Lung: A Neglected Subtype of Hypersensitivity Pneumonitis. Lung 199 (1) (2021)
Nada Taha, Dejanira D'Amato, Karishma Hosein, Tiziana Ranalli, Gianluigi Sergiacomi, Maurizio Zompatori, Marco Mura
Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters? Respiratory research 21 (1) (2020)
Marco Mura, Matthew J Cecchini, Mariamma Joseph, John T Granton
Osteopontin lung gene expression is a marker of disease severity in pulmonary arterial hypertension. Respirology (Carlton, Vic.) 24 (11) (2019)
Marco Mura, Stephen Juvet
Bronchiolitis obliterans syndrome as manifestation of lung GVHD: Not the only one. Respirology (Carlton, Vic.) 24 (7) (2019)
Karishma S Hosein, Gianluigi Sergiacomi, Maurizio Zompatori, Marco Mura
The CALIPER-Revised Version of the Composite Physiologic Index is a Better Predictor of Survival in IPF than the Original Version. Lung 198 (1) (2019)
Hana Serajeddini, Paola Rogliani, Marco Mura
Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity. Lung 196 (6) (2018)
Matthew J Cecchini, Karishma Hosein, Christopher J Howlett, Mariamma Joseph, Marco Mura
Comprehensive gene expression profiling identifies distinct and overlapping transcriptional profiles in non-specific interstitial pneumonia and idiopathic pulmonary fibrosis. Respiratory research 19 (1) (2018)
Karishma Hosein, Jamie Le, Marco Mura
Assessing the Therapeutic Response to Pirfenidone in Idiopathic Pulmonary Fibrosis: Can We Do Better than with Forced Vital Capacity Alone? Lung 195 (1) (2016)

Marco Mura.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Mura